PhaseBio Pharmaceuticals, Inc. Company Profile

10:12 EDT 30th March 2015 | BioPortfolio

PhaseBio Pharmaceuticals, Inc. (PhaseBio), located in Research Triangle Park, NC, is a development stage, privately held protein engineering company focused on developing the next generation of biopharmaceuticals. The company's versatile technology is based on biopolymers of elastin-like repeating subunits to which drugs can be attached or peptides and proteins genetically fused, enhancing the pharmacology and delivery of therapeutics.


News Articles [8 Associated News Articles listed on BioPortfolio]

PhaseBio Pharmaceuticals gets $40M funding boost

A Series C funding round led by AstraZeneca PLC has pulled in $40 million for PhaseBio Pharmaceuticals, a firm focused on bio -More- 

AstraZeneca leads $40 million investment in PhaseBio

PhaseBio Pharmaceuticals has closed a $40 million Series C financing round led by AstraZeneca. Searching for more deal information? Current Partnering offers the following options: CP Reports | ...

AstraZeneca leads PhaseBio series C

PhaseBio Pharmaceuticals Inc. (Malvern, Pa.) raised $20 million in the first tranche of a planned $40 million series C round led by AstraZeneca plc (LSE:AZN; NYSE:AZN). Existing investors New Enterpri...

PhaseBio brings in $40mm in Series C financing led by AstraZeneca

PhaseBio Pharmaceuticals Inc. (metabolic and cardiopulmonary therapies) raised $40mm through its Series C financing led by AstraZeneca, which was joined by returning shareholders New Enterprise Associ...

PhaseBio completes venture financing

PhaseBio Raises $40 Million Series C Financing Led by AstraZeneca

Proceeds to enable advancement of lead drug candidates – once-weekly basal insulin and once-weekly Vasoactive Intestinal Peptide MALVERN, Pa., March 12, 2015 (GLOBE NEWSWIRE) -- PhaseBio Ph...

PhaseBio Announces Expansion of Leadership Team

Clay Thorp named Executive Chairman of the board Jonathan P. Mow becomes Chief Executive Officer Dr. James Ballance appointed Vice President...

BioNotebook: PhaseBio closes $40m Series C round led by AstraZeneca, plus five other VC financings

AstraZeneca led a $40m Series C venture capital round that will fund PhaseBio's Phase IIa clinical trials for drug candidates to treat diabetes and heart failure – two key areas of interest for ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

PhaseBio Pharmaceuticals, Inc.

PhaseBio Pharmaceuticals, Inc. (PhaseBio), located in Research Triangle Park, NC, is a development stage, privately held protein engineering company focused on developing the next...

More Information about "PhaseBio Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of PhaseBio Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of PhaseBio Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about PhaseBio Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PhaseBio Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant PhaseBio Pharmaceuticals, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record